Amalgamated Bank’s ImmunityBio IBRX Stock Holding History

Amalgamated Bank’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92K	Buy	+10,489	New	+$79.4K	﹤0.01%	1616
2026 Q1	–	Sell	-9,272	Closed	-$18K	–	2185
2025 Q4	$18K	Buy	9,272 +4,004	+76%	+$9.07K	﹤0.01%	2155
2025 Q3	$13K	Hold	5,268	–	–	﹤0.01%	2340
2025 Q2	$14K	Hold	5,268	–	–	﹤0.01%	2272
2025 Q1	$16K	Buy	5,268 +745	+16%	+$2.26K	﹤0.01%	2153
2024 Q4	$12K	Hold	4,523	–	–	﹤0.01%	2348
2024 Q3	$17K	Hold	4,523	–	–	﹤0.01%	2195
2024 Q2	$29K	Hold	4,523	–	–	﹤0.01%	1997
2024 Q1	$24K	Sell	4,523 -13,229	-75%	-$59.9K	﹤0.01%	2062
2023 Q4	$89K	Buy	17,752 +3,186	+22%	+$10K	﹤0.01%	2039
2023 Q3	$25K	Hold	14,566	–	–	﹤0.01%	2544
2023 Q2	$40K	Buy	14,566 +3,787	+35%	+$10.7K	﹤0.01%	2416
2023 Q1	$20K	Sell	10,779 -1,760	-14%	-$5.47K	﹤0.01%	2647
2022 Q4	$64K	Hold	12,539	–	–	﹤0.01%	2314
2022 Q3	$62K	Buy	12,539 +161	+1%	+$734	﹤0.01%	2363
2022 Q2	$46K	Buy	12,378 +3,801	+44%	+$15.3K	﹤0.01%	2527
2022 Q1	$48K	Buy	+8,577	New	+$52.6K	﹤0.01%	2504

Other funds holding IBRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.36B AUM 18.79% 1-Year Est. Return

Allen Holding New York $1.01B AUM 14.43% 1-Year Est. Return

Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Amalgamated Bank's IBRX Position: Q2 2026 in Review

Amalgamated Bank opened a new position in ImmunityBio (IBRX) in Q2 2026: 10,489 shares worth $92K. The stake represents ﹤0.01% of the portfolio and ranks #1616 among its holdings. This is a return to the name: Amalgamated Bank previously reported a position in IBRX as recently as Q4 2025.

Amalgamated Bank first reported a position in IBRX in Q1 2022 and has held it in 17 quarters since. 219 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Amalgamated Bank held 10,489 shares of ImmunityBio worth $92K as of Q2 2026.
ImmunityBio was a new Amalgamated Bank position in Q2 2026.
ImmunityBio made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1616 holding.
Amalgamated Bank first reported a position in ImmunityBio in Q1 2022 and has held it in 17 quarters since.
219 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.